Legend Biotech
legend and collaboration legend and have an exclusive global license agreement to advance certain targeted car therapies including an investigational therapy for small cell lung cancer | Legend Biotech
Company
Deck date
April 2025
Slide
20 of 26
Related slides by other companies
Results
November 2022
Investor Day
March 2022
Investor Presentation
May 2020
Other recent decks by Legend Biotech
Results
November 2024
Investor Presentation
January 2024
Results
November 2023
Results
August 2023
Search Thousands of Presentations by World Leading Companies